Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Charming Medical Limited (MCTA) Shareholders to Inquire About Securities Fraud Class Action

Benzinga • Dec 26, 2025 12:43pm (New York) •By Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Charming Medical Limited (MCTA) Shareholders to Inquire About Securities Fraud Class Action

A securities fraud class action lawsuit has been filed against Charming Medical Limited (NASDAQ: MCTA) on behalf of investors who purchased shares between October 10 and November 12, 2025. The SEC halted trading of MCTA securities due to potential market manipulation involving social media-based fraudulent stock promotion schemes. The complaint alleges that company defendants made materially false statements and failed to disclose the fraudulent promotion scheme, insider share dumping, and artificial trading activity driving the stock price.

← Back to news Read Original Article

Insights

MCTA negative

The company is the subject of a securities fraud class action lawsuit, SEC trading halt, and allegations of involvement in a fraudulent stock promotion scheme involving market manipulation, false statements, insider share dumping, and artificial trading activity designed to inflate stock price.

Keywords

#securities fraud #class action lawsuit #market manipulation #social media promotion #SEC trading halt #shareholder rights #stock price inflation

Tickers

MCTA

← Prev: Deadline Alert: Stride, Inc. (LRN) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Next: Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026 →